{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:44Z","timestamp":1791928904713,"version":"4.3.4"},"reference-count":30,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,1,22]]},"DOI":"10.1167\/iovs.67.1.48","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:30:43Z","timestamp":1769092243000},"page":"48","source":"Crossref","is-referenced-by-count":1,"title":["AAV-DJ\u2013Mediated\n                    <i>MYOC<\/i>\n                    Silencing as a Gene Therapy Approach for Myocilin-Associated Glaucoma"],"prefix":"10.1167","volume":"67","author":[{"given":"Yue","family":"Wan","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Yan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Wu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Teng","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyi","family":"Han","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China"},{"name":"Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China"},{"name":"Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"11","key":"bib2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"bib3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.exer.2008.08.011","article-title":"Glaucoma-associated myocilin: a better understanding but much more to learn","volume":"88","author":"Resch","year":"2009","journal-title":"Exp Eye Res"},{"issue":"5","key":"bib4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/hmg\/8.5.899","article-title":"Analysis of myocilin mutations in 1703 glaucoma patients from five different populations","volume":"8","author":"Fingert","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"4","key":"bib5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.survophthal.2021.09.001","article-title":"Juvenile-onset open-angle glaucoma \u2013 a clinical and genetic update","volume":"67","author":"Selvan","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"14","key":"bib6","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1167\/iovs.16-19610","article-title":"Expression of mutant myocilin induces abnormal intracellular accumulation of selected extracellular matrix proteins in the trabecular meshwork","volume":"57","author":"Kasetti","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s10571-022-01280-x","article-title":"Human Pro370Leu mutant myocilin induces the phenotype of open-angle glaucoma in transgenic mice","volume":"43","author":"Cheng","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"900777","DOI":"10.3389\/fcell.2022.900777","article-title":"Myocilin gene mutation induced autophagy activation causes dysfunction of trabecular meshwork cells","volume":"10","author":"Yan","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41420-024-01801-1","article-title":"Serine to proline mutation at position 341 of MYOC impairs trabecular meshwork function by causing autophagy deregulation","volume":"10","author":"Yan","year":"2024","journal-title":"Cell Death Discov"},{"issue":"10","key":"bib10","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1167\/iovs.04-0300","article-title":"Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants","volume":"45","author":"Gobeil","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15 suppl","key":"bib11","first-page":"S279","article-title":"Current therapeutic options and treatments in development for the management of primary open-angle glaucoma","volume":"23","author":"Liebmann","year":"2017","journal-title":"Am J Manag Care"},{"issue":"6","key":"bib12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.survophthal.2025.07.001","article-title":"Trabecular meshwork: a pivotal target for evolving glaucoma treatments","volume":"70","author":"Wan","year":"2025","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/1673-5374.375319","article-title":"The concept of gene therapy for glaucoma: the dream that has not come true yet","volume":"19","author":"Sulak","year":"2024","journal-title":"Neural Regen Res"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exer.2016.04.023","article-title":"Gene transfer to the outflow tract","volume":"158","author":"Dang","year":"2017","journal-title":"Exp Eye Res"},{"issue":"13","key":"bib15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.63.13.15","article-title":"Intracameral injection of AAV-DJ.COMP-ANG1 reduces the IOP of mice by reshaping the trabecular outflow pathway","volume":"63","author":"Qiao","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"109855","DOI":"10.1016\/j.exer.2024.109855","article-title":"Intraocular pressure across the lifespan of Tg-MYOCY437H mice","volume":"241","author":"Zhang","year":"2024","journal-title":"Exp Eye Res"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1038\/s41467-021-25181-7","article-title":"GLIS1 regulates trabecular meshwork function and intraocular pressure and is associated with glaucoma in humans","volume":"12","author":"Nair","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"bib18","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1167\/iovs.14-14263","article-title":"In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI","volume":"55","author":"Ho","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib19","doi-asserted-by":"publisher","first-page":"e0200417","DOI":"10.1371\/journal.pone.0200417","article-title":"Downregulation of splicing regulator RBFOX1 compromises visual depth perception","volume":"13","author":"Gu","year":"2018","journal-title":"PLoS One"},{"issue":"16","key":"bib20","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","article-title":"Preservation of vision after CaMKII-mediated protection of retinal ganglion cells","volume":"184","author":"Guo","year":"2021","journal-title":"Cell"},{"issue":"2","key":"bib21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.4.2.15","article-title":"Reliability of VEP recordings using chronically implanted screw electrodes in mice","volume":"4","author":"Makowiecki","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"bib22","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1172\/JCI58183","article-title":"Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma","volume":"121","author":"Zode","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"bib23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00775-022-01946-3","article-title":"Calcium dysregulation potentiates wild-type myocilin misfolding: implications for glaucoma pathogenesis","volume":"27","author":"Saccuzzo","year":"2022","journal-title":"J Biol Inorg Chem"},{"issue":"42","key":"bib24","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"bib25","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41598-024-57286-6","article-title":"Lentiviral mediated delivery of CRISPR\/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma","volume":"14","author":"Patil","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"bib26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.65.10.22","article-title":"Macrophages modulate optic nerve crush injury scar formation and retinal ganglion cell function","volume":"65","author":"Liu","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"25","key":"bib27","doi-asserted-by":"publisher","first-page":"E3492","DOI":"10.1073\/pnas.1604153113","article-title":"Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo","volume":"113","author":"Zhu","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"bib28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1566523221666210423084233","article-title":"Gene therapy in the anterior eye segment","volume":"22","author":"Amador","year":"2022","journal-title":"Curr Gene Ther"},{"key":"bib29","first-page":"0291","article-title":"AAV for gene therapy in ocular diseases: progress and prospects","volume":"6","author":"He","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"1","key":"bib30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.1.48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:20Z","timestamp":1791927140000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.1.48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.1.48","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}